Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp:
E-Artikel
Titel:
Overexpression of dimethylarginine dimethylaminohydrolase 1 protects from angiotensin II-induced cardiac hypertrophy and vascular remodeling
Beteiligte:
Kopaliani, Irakli;
Jarzebska, Natalia;
Billoff, Silke;
Kolouschek, Anne;
Martens-Lobenhoffer, Jens;
Bornstein, Stefan R.;
Bode-Böger, Stefanie M.;
Ragavan, Vinitha N.;
Weiss, Norbert;
Mangoni, Arduino A.;
Deussen, Andreas;
Rodionov, Roman N.
Erschienen:
American Physiological Society, 2021
Erschienen in:
American Journal of Physiology-Heart and Circulatory Physiology, 321 (2021) 5, Seite H825-H838
Sprache:
Englisch
DOI:
10.1152/ajpheart.00064.2021
ISSN:
0363-6135;
1522-1539
Entstehung:
Anmerkungen:
Beschreibung:
We showed that overexpression of dimethylarginine dimethylaminohydrolase 1 (DDAH1) protects from angiotensin II-induced cardiovascular damage, progression of hypertension, and adverse vascular remodeling in vivo. This protective effect strongly depends on the dose and duration of angiotensin II infusion and is associated with decreased levels of asymmetric dimethylarginine (ADMA), preservation of endothelial function, inhibition of cardiovascular inflammation, as well as lower activity of matrix metalloproteinase-2 (MMP2). Our findings are highly clinically relevant, because they suggest that upregulation of DDAH1 might be a promising therapeutic approach against angiotensin II-induced end organ damage.